Provided by Tiger Trade Technology Pte. Ltd.

Corvus Pharmaceuticals

14.46
+0.13000.91%
Post-market: 14.800.3400+2.35%19:36 EDT
Volume:473.79K
Turnover:6.88M
Market Cap:1.21B
PE:-23.13
High:14.76
Open:14.52
Low:14.38
Close:14.33
52wk High:26.95
52wk Low:5.22
Shares:83.77M
Float Shares:74.12M
Volume Ratio:0.67
T/O Rate:0.64%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.6252
EPS(LYR):-0.5320
ROE:-35.43%
ROA:-21.66%
PB:5.38
PE(LYR):-27.18

Loading ...

Barclays Keeps Their Buy Rating on Corvus Pharmaceuticals (CRVS)

TIPRANKS
·
Aug 07

Corvus Publishes Corporate Presentation Highlighting Soquelitinib ITK Inhibitor Pipeline in Immune Disease and T-Cell Malignancies

Reuters
·
Aug 07

Corvus Pharmaceuticals, Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 07

Corvus Pharma Q2 EPS $(0.19) Misses $(0.17) Estimate

Benzinga Earnings
·
Aug 07

Corvus Pharmaceuticals Schedules Q2 Financial Results Conference Call and Webcast

Reuters
·
Jul 31

Corvus Pharmaceuticals to Provide Business Update and Second Quarter 2026 Financial Results on August 6, 2026

THOMSON REUTERS
·
Jul 31

Corvus Pharmaceuticals Director Ian T. Clark Resigns from Board

Reuters
·
Jul 23

Analysts Are Bullish on Top Healthcare Stocks: Corvus Pharmaceuticals (CRVS), IN8bio (INAB)

TIPRANKS
·
Jul 06

Top Corvus Pharmaceuticals Insider Makes Bold New Bet on the Company’s Future

TIPRANKS
·
Jun 16

Corvus Pharma director David Scott Moore acquires 21,700 common shares for $250,236.72

Reuters
·
Jun 16

Corvus Pharmaceuticals (CRVS) Is Up 7.3% After Promising Soquelitinib Data And Extended Cash Runway

Simply Wall St.
·
Jun 15

Corvus Pharmaceuticals shareholders elect directors at annual meeting

Reuters
·
Jun 13

Mizuho Securities Sticks to Their Buy Rating for Corvus Pharmaceuticals (CRVS)

TIPRANKS
·
Jun 12

BUZZ-U.S. STOCKS ON THE MOVE-Cleveland-Cliffs, Ciena Corp, Nokia Oyj

Reuters
·
Jun 09

BUZZ-U.S. STOCKS ON THE MOVE-Toll Brothers, TG Therapeutics, CECO Environmental

Reuters
·
Jun 09

BUZZ-Corvus rises as it invests in China partner to advance skin, asthma drug trials

Reuters
·
Jun 09

Corvus Pharmaceuticals - Invests $5 Mln in Angel Pharmaceuticals Financing

THOMSON REUTERS
·
Jun 09

Press Release: Corvus Pharmaceuticals Announces Additional Investment in Angel Pharmaceuticals to Advance the Development of Soquelitinib in China

Dow Jones
·
Jun 09

Corvus Pharma posts corporate deck highlighting soquelitinib ITK inhibitor program across immune diseases and T‑cell lymphoma

Reuters
·
Jun 04

Assessing Corvus Pharmaceuticals (CRVS) Valuation After Strong One Year Gains And Recent Share Price Weakness

Simply Wall St.
·
Jun 02